This morning, GlaxoSmithKline announced a $3 billion criminal settlement with the Department of Justice to settle accusations that it didn't tell regulators about safety problems with an infamous ...

GSK lifts long-term sales targets on new drug pipeline - It came as the boss of the London-listed firm cheered an ‘excellent’ ...

Pharmaceutical giant GlaxoSmithKline will shutter its Clifton oral care manufacturing plant on Thursday, and lay off 165 employees, the London-based firm confirmed today. The plant closure is part ...

GlaxoSmithKline PLCGSK-0.10%decrease; red down pointing triangle on Monday said it would buy cancer-focused drug company Tesaro Inc. for about $4.16 billion, positioning the health-care giant in a ...

Incorporated in 1999, GlaxoSmithKline plc (GSK), a British company based in United Kingdom. The company was formed by a merger between Glaxo Wellcome plc and SmithKline Beecham plc. GSK is a ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

Drug maker GlaxoSmithKline PLC said Wednesday it would lay off hundreds of its U.S. workers to reduce costs and to streamline its research and drug-marketing operations by the end of 2015.

April 25 (Reuters) - GlaxoSmithKline (GLAX.NS), opens new tab sued Pfizer (PFE.N), opens new tab and BioNTech (22UAy.DE), opens new tab in Delaware federal court on Thursday, accusing them of ...

Pharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a key senator charged Wednesday, in the latest effort by Democrats to pressure drug companies on the ...

GlaxoSmithKline PLC develops and manufactures innovative vaccines and specialty medications for disease diagnosis, management, and treatment. Research and development (R&D) at GlaxoSmithKline ...

In a market where consistency is key, dividend-paying stocks often offer both income and stability, making them attractive picks for investors. SEBI-registered analyst Prabhat Mittal has spotlighted ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...